WellSpace Health Residential and Withdrawal Management
-
Services:
- Outcome follow-up after discharge
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Detoxification
- Substance use treatment
- Screening for substance use
- Outreach to persons in the community
- Screening for tobacco use
- Comprehensive substance use assessment
- Male
- Female
- State Substance use treatment agency
- The Joint Commission
- State department of health
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Medicaid
- Federal, or any government funding for substance use treatment programs
- SAMHSA funding/block grants
- Cash or self-payment
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Buprenorphine sub-dermal implant
- Clonidine
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Lofexidine
- Naltrexone (extended-release, injectable)
- Medication routinely used during detoxification
- Cocaine Detoxification
- Alcohol Detoxification
- Methamphetamines detoxification
- Opioids detoxification
- In-network prescribing entity
- Trauma-related counseling
- Matrix Model
- Brief intervention
- Cognitive behavioral therapy
- Substance use disorder counseling
- Anger management
- Relapse prevention
- Motivational interviewing
- Mentoring/peer support
- Self-help groups
- Employment counseling or training
- Housing services
- Case management service
- Transportation assistance
- Social skills development
- Early intervention for HIV
- Suicide prevention services
- Smoking permitted in designated area
- Adult men
- Adult women
- Private non-profit organization
- HIV or AIDS education, counseling, or support
- Substance use disorder education
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Adults
- Young Adults
- Residential/24-hour residential
- Long-term residential
- Residential detoxification
- Short-term residential
- Vaping permitted in designated area
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Accepts clients using MAT but prescribed elsewhere
- Lofexidine or Clonidine detoxification
- Buprenorphine detoxification
- Prescribes buprenorphine
- Buprenorphine maintenance
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Drug or alcohol urine screening
- Breathalyzer or blood alcohol testing
- Drug and alcohol oral fluid testing
- In-network prescribing entity
Transitional Services
Type of Care
Assessment/Pre-treatment
Gender Accepted
License/Certification/Accreditation
Opioid Medications used in Treatment
Payment/Insurance/Funding Accepted
Pharmacotherapies
Detoxification (medical withdrawal) Services
External Opioid Medications Source
Treatment Approaches
Recovery Support Services
Ancillary Services
Facility Smoking Policy
Special Programs/Groups Offered
Facility Operation (e.g., Private, Public)
Education and Counseling Services
Age Groups Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Type of Opioid Treatment
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment